One‐Pot Synthesis of Coumarin–Indomethacin Hybrids as COX‐2 Targeting Probes for Cancer Imaging

Sirawit Wet‐osot,Thitima Pewklang,Kantapat Chansaenpak,Nuannoi Chudapongse,Rung‐Yi Lai,Anyanee Kamkaew
DOI: https://doi.org/10.1002/cmdc.202100003
IF: 3.54
2021-03-09
ChemMedChem
Abstract:Facile synthesis of 6‐or 7‐substituted coumarin‐indomathacin hybrids (Coum‐IDM) has been developed for specific cyclooxygenase‐2 (COX‐2) binding along with their intrinsic fluorescent properties.  A mild and rapid condensation/dehydrative cyclization of 2‐hydroxy benzaldehyde with activated indomethacin was carried out in one step under ultrasound irradiation.  Coum‐IDM4 was found to be the best of this series as it presented significant binding to COX‐2 and exhibited higher fluorescent intensity in cancer cell compared to that in the normal cells.  Therefore, in the light of drug development tool, this new hybrid system could be a potential targeted probe for COX‐2 over‐expressed inflammation and cancer cells tracking.
pharmacology & pharmacy,chemistry, medicinal
What problem does this paper attempt to address?